GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (LSE:HCM) » Definitions » Days Sales Outstanding
中文

HUTCHMED (China) (LSE:HCM) Days Sales Outstanding

: 73.13 (As of Dec. 2023)
View and export this data going back to 2006. Start your Free Trial

HUTCHMED (China)'s average Accounts Receivable for the six months ended in Dec. 2023 was £96.6 Mil. HUTCHMED (China)'s Revenue for the six months ended in Dec. 2023 was £241.0 Mil. Hence, HUTCHMED (China)'s Days Sales Outstanding for the six months ended in Dec. 2023 was 73.13.

The historical rank and industry rank for HUTCHMED (China)'s Days Sales Outstanding or its related term are showing as below:

LSE:HCM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.43   Med: 66.13   Max: 73.94
Current: 49.68

During the past 13 years, HUTCHMED (China)'s highest Days Sales Outstanding was 73.94. The lowest was 46.43. And the median was 66.13.

LSE:HCM's Days Sales Outstanding is ranked better than
71.57% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.93 vs LSE:HCM: 49.68

HUTCHMED (China)'s Days Sales Outstanding increased from Dec. 2022 (69.43) to Dec. 2023 (73.13).


HUTCHMED (China) Days Sales Outstanding Historical Data

The historical data trend for HUTCHMED (China)'s Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.94 72.32 67.10 73.20 46.43

HUTCHMED (China) Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.60 69.77 69.43 38.89 73.13

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HUTCHMED (China) Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s Days Sales Outstanding falls into.



HUTCHMED (China) Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HUTCHMED (China)'s Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (77.561 + 90.848) / 2 ) / 662.019*365
=84.2045 / 662.019*365
=46.43

HUTCHMED (China)'s Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (102.329 + 90.848) / 2 ) / 241.049*365 / 2
=96.5885 / 241.049*365 / 2
=73.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HUTCHMED (China)  (LSE:HCM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


HUTCHMED (China) Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


HUTCHMED (China) (LSE:HCM) Business Description

Traded in Other Exchanges
Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) (LSE:HCM) Headlines